Mycotopia Therapies(OTC) TPIA

Current PriceN/A

Market CapN/A

Since IPO (2021)-100%

5 Year-100%

1 Year-93%

1 Month-50%

Mycotopia Therapies last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-07-24

Mycotopia Therapies stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-11.11%	USD 0.00	2026-07-17
1 month	-50%	USD 0.00	2026-06-24
3 month	-55.56%	USD 0.00	2026-04-24
Year to date	-84%	USD 0.00	2025-12-31
1 year	-92.98%	USD 0.01	2025-07-24
3 year	-98.23%	USD 0.02	2023-07-25
5 year	-99.98%	USD 2.00	2021-07-23
Since inception	-99.99%	USD 3.25	2021-01-21

Mycotopia Therapies Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$2.04M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Dec 31, 2022

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Dec 31, 2022

TPIA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mycotopia Therapies

Mycotopia Therapies, Inc. specializes in the application of psychedelic compounds to address various mental health conditions. The company focuses on therapeutic interventions for ailments such as PTSD, severe anxiety, and depression, while also providing support for palliative care.

Products and Services

Therapeutic interventions for mental health conditions
Support for palliative care
Research and development of psychedelic compounds

Growth Outlook

Increasing acceptance of psychedelic therapies in mental health treatment
Expanding market for mental health solutions projected to grow significantly
Potential partnerships with healthcare providers for broader service offerings

Financial Highlights

Recent quarterly net income of -$418,105, reflecting ongoing operational investments
Trailing twelve months (TTM) cash and cash equivalents of $288,858
Operating expenses for Q1 2026 totaled $359,463, indicating a focus on growth

Mycotopia Therapies, Inc. operates in a rapidly evolving sector, with increasing recognition of the potential benefits of psychedelic compounds in treating mental health disorders. The company's commitment to research and development positions it well to capitalize on the growing demand for innovative therapeutic solutions. Recent financial data indicates a focus on operational growth, despite current losses, suggesting a long-term strategy aimed at establishing a strong market presence. The expanding market for mental health solutions and potential partnerships with healthcare providers further enhance the company's growth prospects.

AI Generated • Jul 18, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

CEO

Benjamin Kaplan

Website

www.aibotics.ai

Headquarters

Aventura, FL 33180, US

TPIA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

50.02%

Return on Capital

N/A

Return on Assets

-264.83%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$1.67M

EBITDA

$256.98K

Operating Cash Flow

-$466.14K

Capital Expenditure

$0.00

Free Cash Flow

-$466.14K

Cash & ST Invst.

$288.86K

Total Debt

$165.00K

Mycotopia Therapies Performance Analysis

Mycotopia Therapies annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 0	N/A
2025	2025-12-31	USD 2,183	N/A

Mycotopia Therapies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	-100.0%
Q3	2025-09-30	N/A
Q4	2025-12-31	N/A
Q1	2026-03-31	N/A

Mycotopia Therapies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.18	-52.8%
2023	2023-12-31	USD -0.08	-56.1%
2024	2024-12-31	USD -0.14	73.9%
2025	2025-12-31	USD -0.01	-91.4%

Mycotopia Therapies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	154.8%
Q3	2025-09-30	-111.2%
Q4	2025-12-31	-325.9%
Q1	2026-03-31	93.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$418.11K

+29.3%

EBITDA

$169.96K

+3.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$288.86K

+84.3%

Total Debt

$165.00K

+0.0%

Accounts Receivable

$0.00

N/A

Inventory

$40.53K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$165.00K

+0.0%

Return on Assets

-2.65%

N/A

Return on Invested Capital

39.13%

N/A

Free Cash Flow

-$36.26K

-27.8%

Operating Cash Flow

-$36.26K

-27.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

QTXBQuantRx Biomedical Corporation

QTXBQuantRx Biomedical Corporation$0.00+400.00%

MRVTMiravant Medical Technologies Inc.

MRVTMiravant Medical Technologies Inc.$0.00+29900.00%

POTNPotNetwork Holdings, Inc.

POTNPotNetwork Holdings, Inc.$0.00+0.00%

PPCBPropanc Biopharma, Inc.

PPCBPropanc Biopharma, Inc.$1.37-5.52%

PREDPredictive Technology Group, Inc.

PREDPredictive Technology Group, Inc.$0.00N/A

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$92.32-0.08%

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

Questions About TPIA

What is the current price of Mycotopia Therapies?

Mycotopia Therapies is trading at N/A per share.

What is the 52-week range for Mycotopia Therapies?

Over the past 52 weeks, Mycotopia Therapies has traded between N/A and N/A.

How much debt does Mycotopia Therapies have?

As of the most recent reporting period, Mycotopia Therapies reported total debt of $1.36M.

How much cash does Mycotopia Therapies have on hand?

Mycotopia Therapies reported $288.86K in cash and cash equivalents in its most recent financial results.

What is Mycotopia Therapies’s dividend yield?

Mycotopia Therapies does not currently have a dividend yield.

Mycotopia Therapies(OTC) TPIA

Mycotopia Therapies Financials at a Glance

TPIA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Mycotopia Therapies

TPIA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Mycotopia Therapies Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TPIA

What is the current price of Mycotopia Therapies?

What is the 52-week range for Mycotopia Therapies?

How much debt does Mycotopia Therapies have?

How much cash does Mycotopia Therapies have on hand?

What is Mycotopia Therapies’s dividend yield?

Premium Investing Services